Manufacturer copay assistance · Spinraza (J2326) · Biogen
$0/dose · Maximum benefit No annual maximum publicly disclosed — covers drug and procedure copay · Covers Spinraza drug cost and intrathecal procedure cost — separate enrollment for each
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Spinraza — the program's cap applies against the patient share CareCost calculates.
Yes — Biogen Copay Program for Spinraza from Biogen. Eligible patients may pay $0 for Spinraza drug and procedure costs. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible patients may pay $0 for Spinraza drug and procedure costs Maximum benefit: No annual maximum publicly disclosed — covers drug and procedure copay. Covers Spinraza drug cost and intrathecal procedure cost — separate enrollment for each
Accepted insurance: commercial. Not eligible: medicare, medicaid, tricare, va, dod, government.